Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SCN4A | P35499 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11496623 | 0.90 | CA2 (0.36) | ALDH1A1GABRA1GABRB2CA2TSHR | |
| SCHEMBL11494221 | 0.82 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2CA2TSHRTDP1 | |
| SCHEMBL10343323 | 0.82 | GABRA1 (0.50) | ALDH1A1GABRA1GABRB2SMN1; SMN2KDM4E | |
| SCHEMBL6549343 | 0.79 | ALDH1A1 (0.36) | ALDH1A1GABRA1GABRB2SMN1; SMN2CA2 | |
| SCHEMBL1160000 | 0.78 | GABRA1 (0.48) | ALDH1A1GABRA1GABRB2SMN1; SMN2KDM4E | |
| SCHEMBL2368433 | 0.77 | TDP1 (0.41) | ALDH1A1KDM4EGAATSHRTDP1 | |
| SCHEMBL11488213 | 0.76 | CYP1A2 (0.36) | TSHR | |
| SCHEMBL30640998 | 0.75 | GABRA1 (0.50) | ALDH1A1GABRA1GABRB2SMN1; SMN2KDM4E | |
| SCHEMBL27692244 | 0.75 | GABRA1 (0.50) | ALDH1A1GABRA1GABRB2SMN1; SMN2KDM4E | |
| SCHEMBL8389885 | 0.75 | GABRA1 (0.50) | ALDH1A1GABRA1GABRB2SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1472201-B1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF SE (DE) | 2014-08-13 | — | — | EP | disclosed |
| US-7767852-B2 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| US-7351339-B2 | Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-01 | — | — | US | disclosed |
| EP-1470136-B1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AG (DE) | 2007-03-28 | — | — | EP | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| EP-1472201-A2 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-03 | — | — | EP | disclosed |
| EP-1470136-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003062171-A2 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003062251-A1 | METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | ALDH1A1 4228/4885GABRA1 3675/4885GABRB2 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.